Literature DB >> 29450314

Intraoperative and postoperative complications in trabeculectomy, Clinical study.

Barac Ramona1,2, Pop Monica1,2, Stanciu Paul-Eduard2, Schmitzer Speranta2, Tataru Calin-Petru1,2.   

Abstract

Glaucoma represents a progresive multifactorial optic neuropathy characterised by retinal ganglion cell loss and atrophy of the optic nerve its main cause being high intraocular pressure. [1,2] Trabeculectomy is the most used surgical method when it comes to the majority of the ophthalmologists which is why knowing and managing the intraoperative and postoperative complications well is very important. [3] Objective/aim.The study aims to establish the success rate and to evaluate the intraoperative and postoperative complications in a group of 75 patients with glaucoma 1 year after surgery. Methods. A retrospective study was made on a group of 75 adult patients with different types of glaucoma which were refractory to medical treatment, for whom the treatment option was the trabeculectomy surgical intervention . Results and discussions. The success rate measured 1 year after the surgery was of 89%.The most complications were found in patients with open angle glaucoma, neovascular glaucoma and glaucoma secondary to vitreo-retinal surgery. Trabeculectomy is a surgical procedure associated with numerous complications, so much so that the follow-up and the management of the aforementioned complications are sometimes more laborious than the surgery itself.

Entities:  

Keywords:  glaucoma; intraoperative and postoperative complications; trabeculectomy

Year:  2015        PMID: 29450314      PMCID: PMC5712946     

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  2 in total

1.  Safe trabeculectomy technique: long term outcome.

Authors:  I Stalmans; A Gillis; A-S Lafaut; T Zeyen
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.